Laut einer neuen Umfrage haben die USA den Höhepunkt der Fettleibigkeit überschritten. Ist es der Ozempic-Effekt?
https://www.independent.co.uk/news/health/obesity-rates-us-ozempic-weight-loss-b2624064.html
Laut einer neuen Umfrage haben die USA den Höhepunkt der Fettleibigkeit überschritten. Ist es der Ozempic-Effekt?
https://www.independent.co.uk/news/health/obesity-rates-us-ozempic-weight-loss-b2624064.html
3 Kommentare
My prediction from a month ago.
[https://www.reddit.com/r/Futurology/comments/1fglshc/comment/ln373s4](https://www.reddit.com/r/Futurology/comments/1fglshc/comment/ln373s4)
—
The end of the obesity epidemic. Due to advances in GLP-1-like drugs, the obesity ratio in the US will be under 15% by 2040
**2023-2024 (Obesity Rate: ~42%). We are here**
* Wider Use of Semaglutide (Ozempic/Wegovy)
* Solve availability and shortage production issues
* More healthcare providers adopt GLP-1
**2025-2026 (Obesity Rate: ~39%)**
* Approval for Pediatric Use
* Expanded Insurance Coverage
* Introduction of Oral GLP-1 Drugs
**2027-2028 (Obesity Rate: ~35%)**
* Digital Health Integration
**2029-2030 (Obesity Rate: ~32%)**
* Combination Therapies Introduced
**2031-2032 (Obesity Rate: ~29%)**
* Long-acting formulations (monthly doses)
**2033-2040 (Obesity Rate: ~15%)**
* GLP-1 therapies have become a mainstream component of obesity treatment protocols.
* Preventive Use Exploration
This might look small, but it has significant societal consequences, starting with a longer lifespan average.
The U.S. obesity rate has peaked and declined by 2% between 2020 and 2023, according to a National Health and Nutrition Examination survey. The decrease was seen in both men and women, though severe obesity remained higher in women. Education level played a role, with lower rates in those holding bachelor’s degrees. Weight-loss drugs, like Wegovy and Ozempic, may be contributing to this decline, as more than 15 million Americans are using them. Obesity still affects 2 in 5 adults and 15 million children.
Yes, I imagine there would be a 600% increase in people taking a weight loss drug when it got rebranded as the best weight loss drug instead of a diabetes drug. Kind of wonder if this is an AI post of an AI article or just a random semaglutide ad.